The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
Open accessAbstract
Tuberculosis (TB) remains one of the leading public health problems worldwide. Declared as a global emergency in 1993 by the WHO, its control is hampered by the emergence of multidrug resistance (MDR), defined as resistance to at least rifampicin and isoniazid, two key drugs in the treatment of the disease. More recently, severe forms of drug resistance such as extensively drug-resistant (XDR) TB have been described. After the discovery of several drugs with anti-TB activity, multidrug therapy became fundamental for control of the disease. Major advances in molecular biology and the availability of new information generated after sequencing the genome of Mycobacterium tuberculosis increased our knowledge of the mechanisms of resistance to the main anti-TB drugs. Better knowledge of the mechanisms of drug resistance in TB and the molecular mechanisms involved will help us to improve current techniques for rapid detection and will also stimulate the exploration of new targets for drug activity and drug development. This article presents an updated review of the mechanisms and molecular basis of drug resistance in M. tuberculosis. It also comments on the several gaps in our current knowledge of the molecular mechanisms of drug resistance to the main classical and new anti-TB drugs and briefly discusses some implications of the development of drug resistance and fitness, transmission and pathogenicity of M. tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Self-citationMatsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Makarov, V., Manina, G., Mikusova, K., Möllmann, U., Ryabova, O., Saint-Joanis, B., Dhar, N., Pasca, M. R., Buroni, S., Lucarelli, A. P., et al. (2009) · Science · doi:10.1126/science.1171583 · Cited by 740
Scorpio, A., & Zhang, Y. (1996) · Nature Medicine · doi:10.1038/nm0696-662 · Cited by 726
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis
Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik, G. K., & Bohannan, B. J. M. (2006) · Science · doi:10.1126/science.1124410 · Cited by 627
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv
Camus, J.-C., Pryor, M. J., Médigue, C., & Cole, S. T. (2002) · Microbiology · doi:10.1099/00221287-148-10-2967 · Cited by 597
Mycobacterial cell wall: Structure and role in natural resistance to antibiotics
Jarlier, V (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90267-4 · Cited by 593
The curious characteristics of pyrazinamide: a review.
Zhang, Y., & Mitchison, D. A. (2003) · PubMed · Cited by 586
Diarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547
Wilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
The action of antituberculosis drugs in short-course chemotherapy
Mitchison, D. A. (1985) · Tubercle · doi:10.1016/0041-3879(85)90040-6 · Cited by 518
Hypertension and hyperuricaemia
Nridge, A. B. (1965) · The Lancet · Cited by 496
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
Zhang, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg446 · Cited by 477
The biological cost of mutational antibiotic resistance: any practical conclusions?
Andersson, D. I. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.07.002 · Cited by 472
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Lomovskaya, O., & Bostian, K. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.008 · Cited by 460
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
Zhang, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100120 · Cited by 432
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Gillespie, S. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.267-274.2002 · Cited by 412
Wright, A., Zignol, M., Van Deun, A., Falzon, D., Gerdes, S. R., Feldman, K., Hoffner, S., Drobniewski, F., Barrera, L., van Soolingen, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60331-7 · Cited by 385
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Heym, B., Philipp, W., & Cole, S. T. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80166-2_3 · Cited by 379
Campbell, P. J., Morlock, G. P., Sikes, R. D., Dalton, T. L., Metchock, B., Starks, A. M., Hooks, D. P., Cowan, L. S., Plikaytis, B. B., & Posey, J. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01550-10 · Cited by 379
Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-06 · Cited by 374
Somoskovi, A., Parsons, L. M., & Salfinger, M. (2001) · Respiratory Research · doi:10.1186/rr54 · Cited by 373
Protopopova, M., Hanrahan, C., Nikonenko, B., Samala, R., Chen, P., Gearhart, J., Einck, L., & Nacy, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki319 · Cited by 371
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Rattan, A., Kalia, A., & Ahmad, N. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980207 · Cited by 355
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
Vilchèze, C., & Jacobs, Jr. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.111606.122346 · Cited by 335
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations
Sreevatsan, S., Stockbauer, K. E., Pan, X., Kreiswirth, B. N., Moghazeh, S. L., Jacobs, W. R., Telenti, A., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1677 · Cited by 335
The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis
Braibant, M. (2000) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(00)00034-6 · Cited by 334
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis
Scorpio, A., Lindholm-Levy, P., Heifets, L., Gilman, R., Siddiqi, S., Cynamon, M., & Zhang, Y. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.540 · Cited by 333
Ancestral antibiotic resistance in Mycobacterium tuberculosis
Morris, R. P., Nguyen, L., Gatfield, J., Visconti, K., Nguyen, K., Schnappinger, D., Ehrt, S., Liu, Y., Heifets, L., Pieters, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505446102 · Cited by 333
Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., & Barry, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508392103 · Cited by 331
Zaunbrecher, M. A., Sikes, R. D., Metchock, B., Shinnick, T. M., & Posey, J. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907925106 · Cited by 330
Rawat, R., Whitty, A., & Tonge, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235848100 · Cited by 330
Role of mycobacterial efflux transporters in drug resistance: an unresolved question
Rossi, E. D., Aínsa, J. A., & Riccardi, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00002.x · Cited by 328
Mechanism of fluoroquinolone action
Drlica, K. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00008-9 · Cited by 319
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Vilchèze, C., Wang, F., Arai, M., Hazbón, M. H., Colangeli, R., Kremer, L., Weisbrod, T. R., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2006) · Nature Medicine · doi:10.1038/nm1466 · Cited by 319
Mechanism of thioamide drug action against tuberculosis and leprosy
Wang, F., Langley, R., Gulten, G., Dover, L. G., Besra, G. S., Jacobs, W. R., & Sacchettini, J. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062100 · Cited by 303
Basic Mechanisms of Chemotherapy
Mitchison, D. A. (1979) · Chest · doi:10.1378/chest.76.6.771 · Cited by 301
Okamoto, S., Tamaru, A., Nakajima, C., Nishimura, K., Tanaka, Y., Tokuyama, S., Suzuki, Y., & Ochi, K. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05585.x · Cited by 301
PARA-AMINOSALICYLIC ACID IN THE TREATMENT OF TUBERCULOSIS
Lehmann, J. (1946) · The Lancet · doi:10.1016/s0140-6736(46)91185-3 · Cited by 295
A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., & Blanchard, J. S. (2005) · Science · doi:10.1126/science.1110699 · Cited by 291
Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284
Rustomjee, R., Diacon, A. H., Allen, J., Venter, A., Reddy, C., Patientia, R. F., Mthiyane, T. C. P., De Marez, T., van Heeswijk, R., Kerstens, R., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01204-07 · Cited by 278
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
Cohen, T., & Murray, M. (2004) · Nature Medicine · doi:10.1038/nm1110 · Cited by 277
Maus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3192-3197.2005 · Cited by 273
Streptomycin Resistance in Pulmonary Tuberculosis
Crofton, J., & Mitchison, D. A. (1948) · BMJ · doi:10.1136/bmj.2.4588.1009 · Cited by 261
MOLECULAR MECHANISMS OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
Blanchard, J. S. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001243 · Cited by 255
Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis
Billington, O. J., McHugh, T. D., & Gillespie, S. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1866 · Cited by 251
Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T., & Bodmer, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2054 · Cited by 250
Johansen, S. K., Maus, C. E., Plikaytis, B. B., & Douthwaite, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.044 · Cited by 244
Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine Model
Cynamon, M. H., Klemens, S. P., Sharpe, C. A., & Chase, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1189 · Cited by 243
Aubry, A., Pan, X.-S., Fisher, L. M., Jarlier, V., & Cambau, E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1281-1288.2004 · Cited by 240
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 239
Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
Gagneux, S., Burgos, M. V., DeRiemer, K., Enciso, A., Muñoz, S., Hopewell, P. C., Small, P. M., & Pym, A. S. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020061 · Cited by 230
Some Observations on the Pathogenicity of Isoniazid-Resistant Variants of Tubercle Bacilli
Middlebrook, G., & Cohn, M. L. (1953) · Science · doi:10.1126/science.118.3063.297 · Cited by 217
Flores, A. R., Parsons, L. M., & Pavelka (2005) · Microbiology · doi:10.1099/mic.0.27629-0 · Cited by 217
Huitric, E., Verhasselt, P., Koul, A., Andries, K., Hoffner, S., & Andersson, D. I. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01611-09 · Cited by 215
Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral Therapy
BURMAN, W. J., & JONES, B. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2101133 · Cited by 214
Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Fitness Cost of Chromosomal Drug Resistance-Conferring Mutations
Sander, P., Springer, B., Prammananan, T., Sturmfels, A., Kappler, M., Pletschette, M., & Böttger, E. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1204-1211.2002 · Cited by 213
Larsen, M. H., Vilchèze, C., Kremer, L., Besra, G. S., Parsons, L., Salfinger, M., Heifets, L., Hazbon, M. H., Alland, D., Sacchettini, J. C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03162.x · Cited by 202
Ordway, D., Viveiros, M., Leandro, C., Bettencourt, R., Almeida, J., Martins, M., Kristiansen, J. E., Molnar, J., & Amaral, L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.917-922.2003 · Cited by 200
Aubry, A., Veziris, N., Cambau, E., Truffot-Pernot, C., Jarlier, V., & Fisher, L. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.104-112.2006 · Cited by 197
Colangeli, R., Helb, D., Sridharan, S., Sun, J., Varma‐Basil, M., Hazbón, M. H., Harbacheuski, R., Megjugorac, N. J., Jacobs, W. R., Holzenburg, A., et al. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04510.x · Cited by 188
Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB
Von Groll, A., Martin, A., Jureen, P., Hoffner, S., Vandamme, P., Portaels, F., Palomino, J. C., & da Silva, P. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00287-09 · Cited by 181
Self-citationAeschlimann, J. R. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.7.916.32722 · Cited by 175
Cheng, S.-J., Thibert, L., Sanchez, T., Heifets, L., & Zhang, Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.528-532.2000 · Cited by 175
Rengarajan, J., Sassetti, C. M., Naroditskaya, V., Sloutsky, A., Bloom, B. R., & Rubin, E. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04120.x · Cited by 174
Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis
Pasca, M. R., Guglierame, P., Arcesi, F., Bellinzoni, M., De Rossi, E., & Riccardi, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3175-3178.2004 · Cited by 173
Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
Dye, C. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2048 · Cited by 172
Identification of outer membrane proteins of Mycobacterium tuberculosis
Song, H., Sandie, R., Wang, Y., Andrade-Navarro, M. A., & Niederweis, M. (2008) · Tuberculosis · doi:10.1016/j.tube.2008.02.004 · Cited by 169
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Vilchèze, C., Av‐Gay, Y., Attarian, R., Liu, Z., Hazbón, M. H., Colangeli, R., Chen, B., Liu, W., Alland, D., Sacchettini, J. C., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06365.x · Cited by 168
Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm
Nguyen, L., & Thompson, C. J. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.05.005 · Cited by 167
Multidrug-resistant tuberculosis and its control
Kochi, A., Vareldzis, B., & Styblo, K. (1993) · Research in Microbiology · doi:10.1016/0923-2508(93)90023-u · Cited by 161
Martins, M., Dastidar, S. G., Fanning, S., Kristiansen, J. E., Molnar, J., Pagès, J.-M., Schelz, Z., Spengler, G., Viveiros, M., & Amaral, L. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.025 · Cited by 161
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Heep, M., Rieger, U., Beck, D., & Lehn, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1075-1077.2000 · Cited by 153
Traore, H., Fissette, K., Bastian, I., Devleeschouwer, M. J., & Portaels, F. (2000) · PubMed · Cited by 152
Choudhuri, B. S., Bhakta, S., Barik, R., Basu, J., Kundu, M., & Chakrabarti, P. (2002) · Biochemical Journal · doi:10.1042/bj20020615 · Cited by 151
Arylamine N-acetyltransferases: From Structure to Function
Sim, E., Walters, K. J., & Boukouvala, S. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530802186603 · Cited by 150
Yang, B., Koga, H., Ohno, H., Ogawa, K., Fukuda, M., Hirakata, Y., Maesaki, S., Tomono, K., Tashiro, T., & Kohno, S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.621 · Cited by 148
Genetic Basis for Natural and Acquired Resistance to the Diarylquinoline R207910 in Mycobacteria
Petrella, S., Cambau, E., Chauffour, A., Andries, K., Jarlier, V., & Sougakoff, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00244-06 · Cited by 147
Mathys, V., Wintjens, R. T., Lefevre, P., Bertout, J., Singhal, A., Kiass, M., Kurepina, N. E., Wang, X., Mathema, B., Baulard, A. R., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01197-08 · Cited by 143
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
Rivers, E. C., & Mancera, R. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.004 · Cited by 141
Silva, P. E. A., Bigi, F., Santangelo, M. D. L. P., Romano, M. I., Martín, C., Cataldi, A. A., & Aínsa, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.800-804.2001 · Cited by 141
Multidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis
Stephan, J., Mailaender, C., Etienne, G., Daffé, M., & Niederweis, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4163-4170.2004 · Cited by 139
Fitness of antibiotic-resistant microorganisms and compensatory mutations
Böttger, E. C., Springer, B., Pletschette, M., & Sander, P. (1998) · Nature Medicine · doi:10.1038/3906 · Cited by 138
Safi, H., Sayers, B., Hazbón, M. H., & Alland, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-07 · Cited by 136
Role of Porins for Uptake of Antibiotics by Mycobacterium smegmatis
Danilchanka, O., Pavlenok, M., & Niederweis, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00239-08 · Cited by 135
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 131
Hazbón, M. H., Bobadilla-del-Valle, M., Guerrero, M. I., Basil, M. V., Filliol, I., Cavatore, M., Colangeli, R., Safi, H., Billman‐Jacobe, H., Lavender, C. J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3794-3802.2005 · Cited by 125
First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosis
Richter, E., Rüsch–Gerdes, S., & Hillemann, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-06 · Cited by 117
Silva, M. S. N., Senna, S. G., Ribeiro, M. O., Valim, A. R. D. M., Telles, M. A. S., Kritski, A. L., Morlock, G. P., Cooksey, R. C., Zaha, A., & Rossetti, M. L. R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4471-4474.2003 · Cited by 111
Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatis
Takayama, K., Armstrong, E. L., Kunugi, K. A., & Kilburn, J. O. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.2.240 · Cited by 108
Costa, E. R. D., Ribeiro, M. O., Silva, M. S., Arnold, L. S., Rostirolla, D. C., Cafrune, P. I., Calderon, R. I., Palaci, M., Telles, M. A. S., Ritacco, V., et al. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-39 · Cited by 107
Bhusal, Y., Shiohira, C. M., & Yamane, N. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.05.005 · Cited by 107
Caws, M., Phan, M., Tho, D. Q., Lan, N. T. N., Hoa, D. V., & Farrar, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00330-06 · Cited by 107
Dutta, N. K., Mehra, S., & Kaushal, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010069 · Cited by 104
Sander, P., Belova, L., Kidan, Y. G., Pfister, P., Mankin, A. S., & Böttger, E. C. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03242.x · Cited by 102
Bhakta, S., Besra, G. S., Upton, A. M., Parish, T., Sholto-Douglas-Vernon, C., Gibson, K. J. C., Knutton, S., Gordon, S., daSilva, R. P., Anderton, M. C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031956 · Cited by 98
Pasca, M. R., Degiacomi, G., Ribeiro, A., Zara, F., Mori, P. D., Heym, B., Mirrione, M., Brerra, R., Pagani, L., Pucillo, L. P., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01676-09 · Cited by 92
Nguyen, L., & Pieters, J. (2009) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103123 · Cited by 90
Sun, Z., Zhang, J., Zhang, X., Wang, S., Zhang, Y., & Li, C. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.014 · Cited by 87
Çavuşoğlu, C., Karaca-Derici, Y., & Bilgiç, A. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00917.x · Cited by 79
Siroy, A., Mailaender, C., Harder, D., Körber, S., Wolschendorf, F., Danilchanka, O., Wang, Y., Heinz, C., & Niederweis, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800866200 · Cited by 78
Manina, G., Bellinzoni, M., Pasca, M. R., Neres, J., Milano, A., Ribeiro, A., Buroni, S., Škovierová, H., Dianišková, P., Mikušová, K., et al. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07277.x · Cited by 76
van Doorn, H. R., de Haas, P. E. W., Kremer, K., Vandenbroucke‐Grauls, C. M. J. E., Borgdorff, M. W., & van Soolingen, D. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01495.x · Cited by 66
Lee, A. S. G., Othman, S. N. K., Ho, Y. M., & Wong, S. Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4447-4449.2004 · Cited by 65
O’Sullivan, D. M., McHugh, T. D., & Gillespie, S. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki069 · Cited by 60
Ando, H., Kitao, T., Miyoshi‐Akiyama, T., Kato, S., Mori, T., & Kirikae, T. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07547.x · Cited by 55
Cole, S. T., & Alzari, P. M. (2005) · Science · doi:10.1126/science.1108379 · Cited by 48
Jia, L., Coward, L. C., Gorman, G. S., Noker, P. E., & Tomaszewski, J. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087817 · Cited by 48
David, S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.391 · Cited by 46
Leung, E. T. Y., Ho, P., Yuen, K., Woo, W. L., Lam, T., Kao, R. Y. T., Seto, W., & Yam, W. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1075-1078.2006 · Cited by 44
Cardoso, R. F., Cardoso, M. A., Leite, C. Q. F., Sato, D. N., Mamizuka, E. M., Hirata, R. D. C., de Mello, F. A. F., & Hirata, M. H. (2007) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762007000100009 · Cited by 42
Arylamine N-Acetyltransferases in Mycobacteria
Sim, E., Sandy, J., Evangelopoulos, D., Fullam, E., Bhakta, S., Westwood, I. M., Krylova, A., Lack, N. A., & Noble, M. E. M. (2008) · Current Drug Metabolism · doi:10.2174/138920008784892100 · Cited by 40
Leung, K.-H., Yip, C. W., Yeung, Y. L., Wong, K. L., Chan, W. Y., Chan, M. Y., & Kam, K. M. (2010) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04840.x · Cited by 37
von Groll, A., Martin, A., Felix, C. R., Prata, P. F. S., Honscha, G., Portaels, F., Vandamme, P. A. R., da Silva, P. E. A., & Palomino, J. C. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00611.x · Cited by 36
Self-citationNovel Streptomycin Resistance Gene from Mycobacterium fortuitum
Ramón‐García, S., Otal, I., Martı́n, C., Gómez-Lus, R., & Aínsa, J. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00223-06 · Cited by 35
Wang, Q., Yue, J., Zhang, L., Xu, Y., Chen, J., Zhang, M., Zhu, B., Wang, H., & Wang, H. (2007) · Journal of Proteome Research · doi:10.1021/pr070242z · Cited by 29
Chakravorty, S., Aladegbami, B. G., Motiwala, A. S., Dai, Y. D., Safi, H., Brimacombe, M. B., Helb, D., & Alland, D. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00666-08 · Cited by 27
Motiwala, A. S., Dai, Y. D., Jones‐López, E. C., Hwang, S.-H., Lee, J. S., Cho, S. N., Via, L. E., Barry, C. E., & Alland, D. (2010) · The Journal of Infectious Diseases · doi:10.1086/650999 · Cited by 25
Ribosomal drug resistance in mycobacteria
Sander, P., Meier, A., & Böttger, E. C. (1996) · Research in Microbiology · doi:10.1016/0923-2508(96)80205-1 · Cited by 24
Tuberculosis: evolution in millennia and minutes
Gillespie, S. H. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351317 · Cited by 24
Bhowruth, V., Brown, A. K., & Besra, G. S. (2008) · Microbiology · doi:10.1099/mic.0.2008/017434-0 · Cited by 24
Antimycobacterial Activity and Mechanism of Action of NAS-91
Gratraud, P., Surolia, N., Besra, G. S., Surolia, A., & Kremer, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00968-07 · Cited by 21
Cited by
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Nepali, K., Lee, H.-Y., & Liou, J.-P. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00147 · Cited by 629
Strategies to Minimize Antibiotic Resistance
Lee, C.-R., Cho, I., Jeong, B., & Lee, S. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094274 · Cited by 446
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria
Medina, E., & Pieper, D. H. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_492 · Cited by 356
Metadata
- Authors
- Almeida Da Silva, P. E., & Palomino, J. C.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-05-09
- Volume
- 66
- Issue
- 7
- Pages
- 1417-1430
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2150700849
- Cited by
- 532
- References
- 140
- FWCI
- 24.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.